Read more about the article SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial

SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial

Innovative Cambridge biotech company SolasCure, which is developing a revolutionarywound cleaning technology, has published its pre-clinical results with the InternationalWound Journal, showing preliminary evidence that supports its new enzymatic debridementproduct…

Continue ReadingSolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial
Read more about the article <strong>SolasCure’s David Fairlamb recognised at TOPRA Awards for exceptional leadership in regulatory strategy</strong>

SolasCure’s David Fairlamb recognised at TOPRA Awards for exceptional leadership in regulatory strategy

David Fairlamb, Director of Regulatory Affairs at SolasCure, has been named as a winner at the TOPRA awards. The awards, organised by The Organisation for Professionals in Regulatory Affairs, are…

Continue ReadingSolasCure’s David Fairlamb recognised at TOPRA Awards for exceptional leadership in regulatory strategy